Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Navigating Finances In A Relationship
Emily Irwin, managing director of advice & planning for Wells Fargo’s wealth & investment management arm, joined Cheddar News to discuss financial red flags when finding a partner.
Load More